Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Eclinicalmedicine|May 10, 2024
Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trialsSudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Journal of Clinical Gastroenterology|November 10, 2021
Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel DiseaseElisa Buffone, Shaan Gupta, Bashaar Al Ibrahim, et al.
Gastro Hep Advances|December 9, 2025
Drug Discontinuation and Persistent Symptoms Among Initiators of Bio-Originator and Biosimilar anti-Tumor Necrosis Factor Drugs in Inflammatory Bowel Disease: Real-World Contemporary Data From the CAnadian Network for Advanced Interdisciplinary Methods/CIRC RegistryBanke Oketola, Sasha Bernatsky, Luck Lukusa, et al.
Rheumatology and Therapy|April 10, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN)Dara K Shahrokh, Ronald B Vender, Charles W Lynde, et al.
International Journal of Colorectal Disease|September 20, 2024
Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial ConsortiumVirginia Solitano, Sudheer Kumar Vuyyuru, Yuhong Yuan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease ProgressionNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
World Journal of Gastroenterology|March 11, 2026
Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilarsCristiano S Moura, Albert Etingin, Luck Lukusa, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2022
Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) StudyNeeraj Narula, Emily C L Wong, Cara Pray, et al.
Pageof 19